4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0001209191-22-016537
President and CEO sold 2,493 shares at $112.26 ($279,852)
- President and CEO acquired 40,990 shares (grant or award)
- President and CEO acquired 7,848 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LEONARD JOHN M · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-01 | Exercise or conversion : show line 1 in the form | +7,848 | 727,153 | D | ||
| 2022-01-01 | Sale : show line 2 in the form | −2,493 | $112.26 | $279,852 | 724,660 | D |
| 2022-03-01 | Grant or award : show line 3 in the form | +40,990 | 765,650 | D | ||
| Open-market sales · 2,493 sh · avg $112.26 · $279,852 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-01 | Exercise or conversion : show line 4 in the form Restricted Stock Unit | −7,848 | 23,546 | D |
| 2022-03-01 | Grant or award : show line 5 in the form Stock Option (right to buy) | +59,941 | 59,941 | D |
Loading xslF345X03/doc4.xml…